Albumin-based nanocomposite spheres for advanced drug delivery systems

No Thumbnail Available
Authors
Misak, Heath Edward
Asmatulu, Ramazan
Gopu, Janani Sri
Man, Ka-Poh
Zacharias, Nora M.
Wooley, Paul H.
Yang, Shang-You
Issue Date
2014-01
Type
Article
Language
en_US
Keywords
Drug , Human serum albumin , Magnetic nanoparticles , Poly(lactic-co-glycolic acid) , Submicrometer spheres
Research Projects
Organizational Units
Journal Issue
Alternative Title
Abstract

A novel drug delivery system incorporating human serum albumin, poly(lactic-co-glycolic acid, magnetite nanoparticles, and therapeutic agent(s) was developed for potential application in the treatment of diseases such as rheumatoid arthritis and skin cancer. An oil-in-oil emulsion/solvent evaporation (O/OSE) method was modified to produce a drug delivery system with a diameter of 0.5-2 mu m. The diameter was mainly controlled by adjusting the viscosity of albumin in the discontinuous phase of the O/OSE method. The drug-release study showed that the release of drug and albumin was mostly dependent on the albumin content of the drug delivery system, which is very similar to the drug occlusion-mesopore model. Cytotoxicity tests indicated that increasing the albumin content in the drug delivery system increased cell viability, possibly due to the improved biocompatibility of the system. Overall, these studies show that the proposed system could be a viable option as a drug delivery system in the treatment of many illnesses, such as rheumatoid arthritis, and skin and breast cancers.

Description
Click on the DOI link to access the article (may not be free).
Citation
Misak, Heath Edward; Asmatulu, Ramazan; Gopu, Janani Sri; Man, Ka-Poh; Zacharias, Nora M.; Wooley, Paul H.; Yang, Shang-You. 2014. Albumin-based nanocomposite spheres for advanced drug delivery systems. Biotechnology Journal Special Issue: Biotech Methods and Advances, vol. 9:no. 1:ppg. 163–170
Publisher
John Wiley & Sons, Inc.
License
Journal
Volume
Issue
PubMed ID
DOI
ISSN
1860-6768
EISSN